BridgeMD
New treatment option for Scapular Dyskinesis
Official title Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques in Stroke With Scapular Dyskinesia.
ClinicalTrials.gov ID: NCT07148466
What this study is testing
- What it's testing
- This study aims to fill this gap by investigating the effects of scapular and upper limb proprioceptive neuromuscular facilitation techniques on shoulder pain, upper limb function \& gait in stroke with scapular dyskinesia. This study is a randomized control trial that includes 44 patients which were randomly divided into two groups each containing 22 participants.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 65
You may be able to join if
- Sub-acute
- Age bracket 40-65 years.
- Gender Male or Female.
- Gait baseline score (DGI less than 19)
- Patients with spasticity between grades (+1 and 1) on the Modified Ashworth Scale (MAS).
You likely can't join if
- Inability to communicate/understand instructions.
- Stroke with other neurological conditions.
- Patient with any other psychological and medical condition.
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.